IL114149A0 - Modified avidin and streptavidin molecules and use thereof - Google Patents

Modified avidin and streptavidin molecules and use thereof

Info

Publication number
IL114149A0
IL114149A0 IL11414995A IL11414995A IL114149A0 IL 114149 A0 IL114149 A0 IL 114149A0 IL 11414995 A IL11414995 A IL 11414995A IL 11414995 A IL11414995 A IL 11414995A IL 114149 A0 IL114149 A0 IL 114149A0
Authority
IL
Israel
Prior art keywords
avidin
modified
pct
tyrosine residue
streptavidin
Prior art date
Application number
IL11414995A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL11414995A priority Critical patent/IL114149A0/xx
Publication of IL114149A0 publication Critical patent/IL114149A0/xx
Priority to KR1019970709365A priority patent/KR19990022896A/ko
Priority to AT96918819T priority patent/ATE481417T1/de
Priority to DE69638257T priority patent/DE69638257D1/de
Priority to BR9609241-6A priority patent/BR9609241A/pt
Priority to JP9502873A priority patent/JPH11507920A/ja
Priority to CZ974016A priority patent/CZ401697A3/cs
Priority to HU9900239A priority patent/HUP9900239A3/hu
Priority to AU61353/96A priority patent/AU713417B2/en
Priority to CA002221647A priority patent/CA2221647A1/en
Priority to US08/973,970 priority patent/US5973124A/en
Priority to PCT/IL1996/000014 priority patent/WO1997000329A2/en
Priority to IL12244496A priority patent/IL122444A/en
Priority to CN96195475A priority patent/CN1119353C/zh
Priority to EP96918819A priority patent/EP0871658B1/en
Priority to MXPA/A/1997/010181A priority patent/MXPA97010181A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL11414995A 1995-06-14 1995-06-14 Modified avidin and streptavidin molecules and use thereof IL114149A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IL11414995A IL114149A0 (en) 1995-06-14 1995-06-14 Modified avidin and streptavidin molecules and use thereof
EP96918819A EP0871658B1 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
CZ974016A CZ401697A3 (cs) 1995-06-14 1996-06-13 Modifikovaná molekula typu avidin vázající biotin, její použití, nitro-tyrosinový přírodní avidin a způsob jeho výroby, bakteriální streptavidin, kolona pro imobolizaci biotinylovaného ligandu a způsob získání avidinové kolony nebo biotinylovaného ligandu
AU61353/96A AU713417B2 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
DE69638257T DE69638257D1 (de) 1995-06-14 1996-06-13 Modifiziertes avidin und streptavidin und methoden zu ihrer verwendung
BR9609241-6A BR9609241A (pt) 1995-06-14 1996-06-13 Moléculas de avidina e estreptavidina modificadas e uso das mesmas.
JP9502873A JPH11507920A (ja) 1995-06-14 1996-06-13 修飾アビジンおよびストレプトアビジン分子ならびにこれらの使用
KR1019970709365A KR19990022896A (ko) 1995-06-14 1996-06-13 변성 아비딘 및 스트렙트아비딘 분자 및 그 사용
HU9900239A HUP9900239A3 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
AT96918819T ATE481417T1 (de) 1995-06-14 1996-06-13 Modifiziertes avidin und streptavidin und methoden zu ihrer verwendung
CA002221647A CA2221647A1 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
US08/973,970 US5973124A (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
PCT/IL1996/000014 WO1997000329A2 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
IL12244496A IL122444A (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof
CN96195475A CN1119353C (zh) 1995-06-14 1996-06-13 经修饰的抗生物素蛋白和抗生蛋白链菌素及其应用
MXPA/A/1997/010181A MXPA97010181A (en) 1995-06-14 1997-12-15 Modified molecules of avidina and estreptoavidina and use of mis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11414995A IL114149A0 (en) 1995-06-14 1995-06-14 Modified avidin and streptavidin molecules and use thereof

Publications (1)

Publication Number Publication Date
IL114149A0 true IL114149A0 (en) 1995-10-31

Family

ID=11067612

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11414995A IL114149A0 (en) 1995-06-14 1995-06-14 Modified avidin and streptavidin molecules and use thereof

Country Status (14)

Country Link
US (1) US5973124A (xx)
EP (1) EP0871658B1 (xx)
JP (1) JPH11507920A (xx)
KR (1) KR19990022896A (xx)
CN (1) CN1119353C (xx)
AT (1) ATE481417T1 (xx)
AU (1) AU713417B2 (xx)
BR (1) BR9609241A (xx)
CA (1) CA2221647A1 (xx)
CZ (1) CZ401697A3 (xx)
DE (1) DE69638257D1 (xx)
HU (1) HUP9900239A3 (xx)
IL (1) IL114149A0 (xx)
WO (1) WO1997000329A2 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637718A1 (de) * 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
US6368813B1 (en) 1997-03-14 2002-04-09 The Trustees Of Boston University Multiflavor streptavidin
US6391571B1 (en) 1997-04-01 2002-05-21 Roche Diagnostics Gmbh Recombinant inactive avidin mutants
US5985658A (en) * 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
WO2000028326A1 (fr) * 1998-11-06 2000-05-18 Iatron Laboratories, Inc. Nouveaux complexes contenant de l'avidine reticulee, procede analytique dans lequel on utilise de l'avidine reticulee, reactifs et kits d'analyse
IL126991A0 (en) 1998-11-10 1999-09-22 Yeda Res & Dev Azobenzene derivatives and intermediates thereof
WO2000027814A1 (en) * 1998-11-10 2000-05-18 Yeda Research And Development Co. Ltd. Avidin derivatives and uses thereof
JP2002541818A (ja) * 1999-04-14 2002-12-10 ザ ガヴァメント オブ ザ ユナイテッド ステイツ オブ アメリカ、アズ レプリゼンテッド バイ ザ セクレタリー、 デパートメント オブ ヘルス アンド ヒューマン サーヴィスィズ 高感度ファージ提示生体分子検出
WO2001009141A1 (fr) * 1999-07-29 2001-02-08 National Institute Of Advanced Industrial Science And Technology Derives de biotine polymerisables, polymere de la biotine et polymere reagissant a la stimulation de l'avidine
JP2004501110A (ja) * 2000-05-23 2004-01-15 ネクセル　セラピューティックス　インコーポレイティド 細胞選択用試薬および使用方法
GB0102568D0 (en) 2001-02-01 2001-03-21 Magnetic Biosolutions Sweden A Method
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
US20030175818A1 (en) * 2002-03-15 2003-09-18 Ross Amelia A. Devices and methods for isolating and recovering target cells
US9302242B2 (en) * 2004-04-28 2016-04-05 University Of Houston System Preparation of nanometric arrays of biomolecules on oligo- or poly(ethylene glycol) films on silicon surfaces
US8426028B2 (en) * 2004-04-28 2013-04-23 University Of Houston Preparation of sensors on oligo- or poly (ethylene glycol) films on silicon surfaces
WO2006086019A2 (en) * 2004-10-21 2006-08-17 Optiscan Biomedical Corporation Methods of treating diabetes
WO2006084388A1 (en) * 2005-02-11 2006-08-17 Uti Limited Partnership Monomeric streptavidin muteins
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
US7704708B2 (en) * 2006-02-13 2010-04-27 Uti Limited Partnership Monomeric streptavidin muteins
EP2038320B1 (en) 2006-06-29 2014-03-12 Life Technologies AS Particles containing multi- block polymers
CN101622340A (zh) * 2006-11-15 2010-01-06 茵维特罗根戴纳股份公司 生物素化合物与支持物可逆结合的方法
US8506993B2 (en) * 2007-08-14 2013-08-13 University Of Houston Compositions and methods for making and using multifunctional polymerized liposomes
US7842475B2 (en) * 2008-01-08 2010-11-30 Siemens Healthcare Diagnostics Inc. Stabilization of solid support assay reagents
US20090209447A1 (en) * 2008-02-15 2009-08-20 Michelle Meek Cleaning compositions
TWI365185B (en) * 2008-07-24 2012-06-01 Lilly Co Eli Amidophenoxyindazoles useful as inhibitors of c-met
DE102008053892A1 (de) 2008-10-30 2010-05-06 Fachhochschule Gelsenkirchen Medizinisches Implantat mit biofunktionalisierter Oberfläche
EP3462174B1 (en) 2013-03-15 2021-12-29 Arizona Board of Regents on behalf of Arizona State University Biosensor microarray compositions and methods
CN105308437B (zh) 2013-03-15 2018-01-19 Hycor 生物医学有限责任公司 进行样本的冷光和荧光测量的装置和相关方法
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
CA3041059C (en) 2016-10-21 2023-09-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Molecular nanotags

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3027770B2 (ja) * 1994-03-05 2000-04-04 ロシュ ダイアグノスティックス ゲーエムベーハー イムノアッセイで使用するための干渉除去剤

Also Published As

Publication number Publication date
DE69638257D1 (de) 2010-10-28
HUP9900239A2 (hu) 1999-05-28
ATE481417T1 (de) 2010-10-15
AU6135396A (en) 1997-01-15
WO1997000329A3 (en) 1997-03-06
CN1191018A (zh) 1998-08-19
BR9609241A (pt) 1999-10-13
KR19990022896A (ko) 1999-03-25
HUP9900239A3 (en) 1999-11-29
EP0871658B1 (en) 2010-09-15
JPH11507920A (ja) 1999-07-13
CA2221647A1 (en) 1997-01-03
US5973124A (en) 1999-10-26
MX9710181A (es) 1998-03-31
EP0871658A4 (en) 2002-12-04
EP0871658A2 (en) 1998-10-21
CN1119353C (zh) 2003-08-27
AU713417B2 (en) 1999-12-02
WO1997000329A2 (en) 1997-01-03
CZ401697A3 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
IL114149A0 (en) Modified avidin and streptavidin molecules and use thereof
AU3092997A (en) Thermosetting, aqueous compositions
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
AU2958497A (en) Preparation of polyalkeneamines
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
ATE181921T1 (de) Chromatographische isolierung von nucleinsäuren
BG102362A (en) New derivatives of amino acids, their preparation and application
AU2838497A (en) Process for the preparation of substituted aryllactic acid- containing cyclodepsipeptides having 24 ring atoms
ATE401896T1 (de) Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
RS50831B (sr) Izolovano antitelo ili fragment antitela koji se specifično vezuju za rg1 polipeptid
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
AU3711597A (en) A novel galanin receptor
DK91092D0 (xx)
AU3166295A (en) Imidazopyridine-azolidinones
BG104707A (en) Caspase-8 interacting proteins
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
DE69518246T2 (de) Aminosäuren konjugaten
ATE214098T1 (de) Neue cephalosporin-c-acylase
AU3651997A (en) Constructs and complexes of cyclin e
GB9723825D0 (en) Nuclear targeting by means of bacterial proteins
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
DE59611353D1 (de) Transketolase-verwandtes protein
AU3569995A (en) Muramyl peptide compositions for inhibiting hiv replication
BR9202803A (pt) Vetor de dna,processo para produzir,em uma linha linhagem de bacillus thuringiensis,uma proteina exogena desejada,linhagem de bacillus thuringiensis,composicao inseticida e origem de replicagem
KR920002170A (ko) 미생물 효소를 이용한 탈취제